CGTX vs BIIB: Which Stock is Better?
Side-by-side comparison of Cognition Therapeutics Inc and Biogen Inc in 2026
CGTX
Cognition Therapeutics Inc
$1.11
BIIB
Biogen Inc
$177.35
Key Metrics Comparison
| Metric | CGTX | BIIB | Winner |
|---|---|---|---|
| Market Cap | $97.40M | $26.03B | BIIB |
| P/E Ratio | N/A | 20.04 | BIIB |
| EPS (TTM) | $N/A | $8.85 | BIIB |
| Revenue Growth | 0.0% | -0.1% | BIIB |
| Gross Margin | 0.0% | 78.9% | BIIB |
Analyze CGTX
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CGTX or BIIB a better investment?
Comparing CGTX and BIIB: Cognition Therapeutics Inc has a market cap of $97.40M while Biogen Inc has $26.03B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CGTX and BIIB?
CGTX (Cognition Therapeutics Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CGTX or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CGTX or BIIB?
CGTX has higher revenue growth at 0.0% vs -0.1% for BIIB.
Which company is more profitable: CGTX or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 0.0% for CGTX.
Which is the larger company: CGTX or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.03B compared to $97.40M for CGTX.
Should I buy CGTX or BIIB in 2026?
Both CGTX and BIIB have investment merit. CGTX trades at $1.11 while BIIB trades at $177.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CGTX and BIIB stock?
Key differences: Market Cap ($97.40M vs $26.03B), P/E Ratio (N/A vs 20.0x), Revenue Growth (0.0% vs -0.1%), Gross Margin (0.0% vs 78.9%).